Clinical trial
Abatacept Versus Adalimumab Head-to-Head
NCT00929864
Study timeline
Study start (unknown)2009-10-01Date precision: month
Registry last updated2014-02-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Rheumatoid Arthritisunresolved
Interventions
AbataceptDRUG · verified · RxNorm: abatacept
AdalimumabDRUG · verified · RxNorm: adalimumab
Sponsors & collaborators
Bristol-Myers Squibblead sponsor
Mapped research locations
Oklahoma CityOklahoma, United States3AtlantaGeorgia, United States2BirminghamAlabama, United States2TorranceCalifornia, United States2LimaPeru2HoustonTexas, United States1BostonMassachusetts, United States1DallasTexas, United States1St LouisMissouri, United States1MiamiFlorida, United States1San DiegoCalifornia, United States1AustinTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00929864 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.